Literature DB >> 9740519

Clinical and pathologic correlates of stillbirths in a single institution.

D Ogunyemi1, U Jackson, S Buyske, A Risk.   

Abstract

BACKGROUND: To evaluate risk factors, placental and pathologic determinants of stillbirths.
METHODS: A retrospective analysis of stillbirths > or = 25 weeks was performed. Clinical data was compared to a randomized control group. Statistical analysis included chi square test, student t test, and logistic regression.
RESULTS: One hundred and fifteen stillbirths and 193 controls were analyzed. Maternal age, nulliparity, tobacco use, previous induced abortions, anticardiolipid antibodies, elevated maternal serum alpha feto protein, twins, and amniocentesis, were significantly associated with stillbirth. Logistic regression analysis showed only maternal age, tobacco use, small for gestational age (SGA), previous induced abortions, decreasing gestational age as independent significant variables. The stillbirth baby was 6.8 times more likely to be SGA and 11.9 times more likely to be preterm. Primary pathologic diagnoses were placental factors (37%), cord complications (28%), and fetal causes (15%), 17% had maternal risk factors only and 3% had no known risk factors. Diagnosis was suggested by pathology in 40% of cases.
CONCLUSIONS: Stillbirth delivery is associated with older, nulliparous patients with prenatal complications resulting in intrauterine growth retardation and prematurity. Perinatal histopathologic examination is important in diagnosis. Utilizing an extensive testing protocol will reduce the diagnosis of unexplained stillbirth.

Entities:  

Mesh:

Year:  1998        PMID: 9740519

Source DB:  PubMed          Journal:  Acta Obstet Gynecol Scand        ISSN: 0001-6349            Impact factor:   3.636


  8 in total

1.  Placental findings in singleton stillbirths.

Authors:  Halit Pinar; Robert L Goldenberg; Matthew A Koch; Josefine Heim-Hall; Hal K Hawkins; Bahig Shehata; Carlos Abramowsky; Corette B Parker; Donald J Dudley; Robert M Silver; Barbara Stoll; Marshall Carpenter; George Saade; Janet Moore; Deborah Conway; Michael W Varner; Carol J R Hogue; Donald R Coustan; Elena Sbrana; Vanessa Thorsten; Marian Willinger; Uma M Reddy
Journal:  Obstet Gynecol       Date:  2014-02       Impact factor: 7.661

2.  Unilateral uterine ischemia/reperfusion-induced bilateral fetal loss and fetal growth restriction in a murine model require intact complement component 5.

Authors:  Xiao-Wu Qu; Tamas Jilling; Mark G Neerhof; Kehuan Luo; Emmet Hirsch; Larry G Thaete
Journal:  J Reprod Immunol       Date:  2012-06-09       Impact factor: 4.054

3.  Case-control study of factors associated with intrauterine fetal deaths.

Authors:  Savvas Efkarpidis; Evangelos Alexopoulos; Lucy Kean; David Liu; Toby Fay
Journal:  MedGenMed       Date:  2004-05-27

4.  [Evaluation of intrauterine death: importance of examination of fetal, placental and maternal factors].

Authors:  L Freitag; C von Kaisenberg; H H Kreipe; K Hussein
Journal:  Pathologe       Date:  2014-02       Impact factor: 1.011

5.  Disorders of placental villous maturation in fetal death.

Authors:  Sunil Jaiman; Roberto Romero; Percy Pacora; Eunjung Jung; Gaurav Bhatti; Lami Yeo; Yeon Mee Kim; Bomi Kim; Chong Jai Kim; Jung-Sun Kim; Faisal Qureshi; Suzanne M Jacques; Offer Erez; Nardhy Gomez-Lopez; Chaur-Dong Hsu
Journal:  J Perinat Med       Date:  2020-04-01       Impact factor: 1.901

6.  Histological chorioamnionitis is increased at extremes of gestation in stillbirth: a population-based study.

Authors:  Adrienne Gordon; Monica Lahra; Camille Raynes-Greenow; Heather Jeffery
Journal:  Infect Dis Obstet Gynecol       Date:  2011-07-19

7.  Placental pathology, perinatal death, neonatal outcome, and neurological development: a systematic review.

Authors:  Annemiek M Roescher; Albert Timmer; Jan Jaap H M Erwich; Arend F Bos
Journal:  PLoS One       Date:  2014-02-25       Impact factor: 3.240

8.  The risk factors for unexplained antepartum stillbirths in Scotland, 1994 to 2003.

Authors:  R Sutan; D Campbell; G J Prescott; W C S Smith
Journal:  J Perinatol       Date:  2009-10-15       Impact factor: 2.521

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.